Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02110108 · ClinicalTrials.gov registry record · NA
Study for the RevLite Laser System for Facial Solar Lentigines
A NA study of Facial Solar Lentigines, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT02110108 is a NA study of Facial Solar Lentigines that has completed, run by Cynosure. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02110108, a NA study of Facial Solar Lentigines, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the effects of the Revlite Laser System for treatment of facial solar lentigines
Conditions Studied
Interventions
- DEVICE Revlite Laser System
Study Locations (1)
New York
- Sadick Research Group - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02110108
The ClinicalTrials.gov registry entry for NCT02110108 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cynosure, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Facial Solar Lentigines appearing as the primary indexed condition, and to 1 intervention - of which Revlite Laser System is the first listed.
NCT02110108 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02110108 about?
NCT02110108 is a clinical study titled "Study for the RevLite Laser System for Facial Solar Lentigines". The purpose of this study is to evaluate the effects of the Revlite Laser System for treatment of facial solar lentigines
What is the current status of trial NCT02110108?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2014-03. Estimated completion is 2015-02.
What conditions does trial NCT02110108 study?
This clinical trial studies the following conditions: Facial Solar Lentigines.
What interventions are being tested in trial NCT02110108?
The interventions under investigation include: Revlite Laser System (DEVICE).
Who is sponsoring clinical trial NCT02110108?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02110108 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.